» Filings & Approvals
Amgen’s Denosumab Does Well, but Not Many Details on Side Effects
July 8, 2009 at 8:55 am EST |
Add A Comment |
Add A Comment |
Cell Therapeutics Note: OPAXIO/EMEA Meeting in September (Vote on OPAXIO!)
July 7, 2009 at 11:28 am EST |
1 Comment |
1 Comment |
Acorda, Biogen in Ex-U.S. Deal for Fampridine-SR; No U.S.?
July 1, 2009 at 9:37 am EST |
Add A Comment |
Add A Comment |
AMAG’s Feraheme Gets Approval, So Does This Answer Our Question About the FDA?
June 30, 2009 at 8:39 pm EST |
1 Comment |
1 Comment |
Cell Therapeutics Added to Russell Indexes, Shares Still Down
June 30, 2009 at 10:59 am EST |
1 Comment |
1 Comment |
Hemispherx Biopharma Annual Stockholder Meeting Comes and Goes, but Still No FDA Update on Ampligen
June 24, 2009 at 6:09 pm EST |
1 Comment |
1 Comment |
Acura Pharmaceuticals: FDA Backed Up or Complete Response Coming?
June 23, 2009 at 5:23 pm EST |
Add A Comment |
Add A Comment |
The Street’s Adam Feuerstein’s Prediction: HEB Will Pull Ampligen NDA
June 22, 2009 at 2:23 pm EST |
Add A Comment |
Add A Comment |
Connect With Us!
Advertisement
Tags
![[Loading...]](http://www.iguanabio.com/wp-content/themes/IguanaBio/images/ajax-loader.gif){kind=small}
Recent Comments
Blogroll
Recent Tweets
